Knee and hip osteoarthritis (OA) are two of the leading causes of disability globally. Knee OA is characterized by gradual degeneration of articular cartilage, leading to pain, stiffness, and functional limitations. Patients older than 50 years typically present with knee OA, but it can manifest earlier, particularly following traumatic knee injuries. Symptoms include pain, effusion, stiffness, and reduced range of motion. Radiographs commonly are used to confirm a diagnosis of knee OA. Nonsurgical management options include weight loss, lifestyle interventions, orthotic and assistive devices, pain medications (eg, nonsteroidal anti-inflammatory drugs, acetaminophen), and intra-articular injections. The main injectable treatments are corticosteroids, platelet-rich plasma, and hyaluronic acid. These are used as adjunctive therapies for knee OA. It is essential to differentiate between knee and hip OA and understand differences in patient characteristics, treatment approaches, and outcomes. Knee OA can be successfully managed with nonsurgical treatments. Many patients with knee OA can achieve pain relief and improved function without surgery. In contrast, for hip OA there is no evidence that delaying total hip arthroplasty is beneficial. Total hip arthroplasty is considered one of the most effective orthopedic procedures and typically results in pain relief and restoration of joint function in patients with hip OA.

Case 1. GH is a 57-year-old patient with history of coronary artery disease, hypertension, and type 2 diabetes who presents with pain and stiffness in the left knee. The history indicates that he tore the anterior cruciate ligament in a snow skiing accident when he was a teenager. GH says his knee symptoms have slowly worsened over the past decade. He says his knee function is better overall with regular physical activity, but more intense exercise and activities performed on uneven ground, such as backpacking, usually result in increased pain and swelling. He says ibuprofen helps but wonders about the safety of its long-term use.

Definitions and Prevalence

Knee osteoarthritis (OA) is characterized by gradual degeneration of articular cartilage, leading to pain, stiffness, and functional limitations. It is ubiquitous among athletes who play contact and collision sports due to repetitive joint loading and trauma.1

Hip OA is a chronic, degenerative joint disease in which the joint cartilage gradually wears down, leading to pain, stiffness, and reduced mobility. This results in secondary bony and synovial changes as well as characteristic clinical and radiographic findings. Hip OA is common in older adults but can also affect younger individuals, particularly those with previous joint injuries, excessive body weight, or genetic predisposition to joint conditions.2

Worldwide, millions of individuals have OA. Knee and hip OA are two of the leading causes of disability globally.3

In the United States, knee OA is more common than hip OA, with a prevalence of 33.6% in adults 65 years and older. There is a greater prevalence of knee OA in women than men (42.1% vs 31.2%, respectively). The prevalence of radiographic knee OA in individuals older than 45 years is slightly higher in women than men, with rates varying across studies and geographic areas. Sex-based prevalence differences are greater after menopause.4

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.